The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period. This growth is primarily driven by the rising demand for biologics and ...
VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ...
A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...
A study led by the Peter Doherty Institute for Infection and Immunity found there is a worrying increase in strep bacteria growing at rapidly different rates in different parts of the country. The ...
Technology isn’t the biggest challenge. Culture is. by Tim Fountaine, Brian McCarthy and Tamim Saleh Artificial intelligence is reshaping business—though not at the blistering pace many assume. True, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback